NS
Neelam Singh
About Neelam Singh
Data last updated:
Neelam Singh is a Director at Gramen Botanicals Private Limited (since 2020) and Director at Folius Laboratories Private Limited (since 2021). The companies operate in Pharma, Chemicals and Other Industry. The 2 current companies with reported revenue have a combined latest revenue of ₹16.22 Cr; the largest is Gramen Botanicals Private Limited at ₹15.88 Cr (FY 2025). Earlier, Neelam Singh was a Designated Partner at Astragaia Labs Llp (2020–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Gramen Botanicals Private Limited U85100UR2020PTC010675 | Director | 15 Nov 2020 | 2020 | ₹15.88 Cr (FY 2025) | Active |
| Folius Laboratories Private Limited U24290HR2021PTC095388 | Director | 02 Jun 2021 | 2021 | ₹34.3 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Astragaia Labs Llp AAQ-4218 | Designated Partner | 08 Sep 2020 | 2019 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Neelam Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Samarth Vikram Singh | 08550368 | Gramen Botanicals Private Limited , Folius Laboratories Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Neelam Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neelam Singh
Neelam Singh currently holds 2 directorships: Gramen Botanicals Private Limited (Director, since 15 Nov 2020, revenue ₹15.88 Cr (FY 2025)); Folius Laboratories Private Limited (Director, since 02 Jun 2021, revenue ₹34.3 Lakh (FY 2024)).
Neelam Singh was first appointed on 08 Sep 2020 as Designated Partner at Astragaia Labs Llp. The most recent appointment on record is 02 Jun 2021 at Folius Laboratories Private Limited.
The 2 current companies of Neelam Singh that report revenue have a combined latest revenue of ₹16.22 Cr: Gramen Botanicals Private Limited ₹15.88 Cr (FY 2025); Folius Laboratories Private Limited ₹34.3 Lakh (FY 2024).
Neelam Singh held 1 earlier board appointment: Astragaia Labs Llp (Designated Partner, 08 Sep 2020 to 01 Jan 2025).
The current boards of Neelam Singh's companies include Samarth Vikram Singh (Gramen Botanicals Private Limited).